skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
HPV-16 E6 Peptides Vaccine/Candida albicans Extract (Code C102874)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: HPV-16 E6 Peptides Vaccine/Candida albicans Extract

Definition: A human papillomavirus (HPV) type 16 vaccine containing four E6 peptides in combination with the extract of Candida albicans, with potential immunomodulating activity. Upon administration of HPV-16 E6 peptides vaccine/Candida albicans extract, the four HPV-16 E6 peptides and the candida albicans may activate the immune system to mount a cytotoxic T lymphocyte (CTL) response against cells expressing the E6 oncoprotein, resulting in tumor cell lysis. The HPV 16 transforming protein E6 is expressed in precancerous and malignant cervical lesions. Candida albicans allergenic extract may be used as a recall antigen to stimulate the immune system against HPV.

Label: HPV-16 E6 Peptides Vaccine/Candida albicans Extract

NCI Thesaurus Code: C102874 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL437177  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
HPV-16 E6 Peptides Vaccine/Candida albicans Extract
HPV-16 E6 Peptides Vaccine/Candin

External Source Codes: 
PDQ Closed Trial Search ID 738026
PDQ Open Trial Search ID 738026 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C102874
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom